FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter King

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Phenomena

Virus Integration

Concepts & Ideas

Anatomy

Cell Line

Co-author Network

Publications

TOP 3
Hirotoshi Tamura; Takashi Akioka; Koichi Ueno; Takeshi Chujyo; Katsu-ichiro Okazaki; Peter J King; W Edward Robinson
Anti-human immunodeficiency virus activity of 3,4,5-tricaffeoylquinic acid in cultured cells of lettuce leaves.
Ryan A Reinke; Deborah J Lee; Brenda R McDougall; Peter J King; Joseph G Victoria; Yingqun Mao; Xiangyang Lei; Manfred G Reinecke; W Edward Robinson
L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro.
Peter J King; Deborah J Lee; Ryan A Reinke; Joseph G Victoria; Keola Beale; W Edward Robinson
Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter King (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Hirotoshi Tamura; Takashi Akioka; Koichi Ueno; Takeshi Chujyo; Katsu-ichiro Okazaki; Peter J King; W Edward Robinson
Anti-human immunodeficiency virus activity of 3,4,5-tricaffeoylquinic acid in cultured cells of lettuce leaves.
Molecular nutrition & food research 2006;50(4-5):396-400.
2004: Ryan A Reinke; Deborah J Lee; Brenda R McDougall; Peter J King; Joseph G Victoria; Yingqun Mao; Xiangyang Lei; Manfred G Reinecke; W Edward Robinson
L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro.
Virology 2004;326(2):203-19.
2003: Peter J King; Deborah J Lee; Ryan A Reinke; Joseph G Victoria; Keola Beale; W Edward Robinson
Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors.
Virology 2003;306(1):147-61.
2002: Ryan A Reinke; Peter J King; Joseph G Victoria; Brenda R McDougall; Guoxiang Ma; Yingqun Mao; Manfred G Reinecke; W Edward Robinson
Dicaffeoyltartaric acid analogues inhibit human immunodeficiency virus type 1 (HIV-1) integrase and HIV-1 replication at nontoxic concentrations.
Journal of medicinal chemistry 2002;45(17):3669-83.
1999: Peter J King; G Ma; W Miao; Q Jia; Brenda R McDougall; Manfred G Reinecke; C Cornell; J Kuan; T R Kim; W Edward Robinson
Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
Journal of medicinal chemistry 1999;42(3):497-509.
1998: Peter J King; W Edward Robinson
Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase.
Journal of virology 1998;72(10):8420-4.
1998: Brenda R McDougall; Peter J King; B W Wu; Z Hostomsky; Manfred G Reinecke; W Edward Robinson
Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.
Antimicrobial agents and chemotherapy 1998;42(1):140-6.